66 unknown. 66 Phase 2, 10 Phase 3, 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 66 | Unknown 66 |
| Phase 3 | 10 | Unknown 10 |
| Phase 1 | 7 | Unknown 7 |
Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma Salbutamol, Fluticason either Beclometasone or Budesonide - Asthma | Phase 2 | Unknown | Università degli Studi di Ferrara | 80 | 2024-06-18 | 2024-07-03 |
| A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC Adebrelimab, Carboplatin/Cisplatin, Etoposide - Respiratory Tract Neoplasms, Thoracic Neoplasms | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 62 | 2023-12-10 | 2023-12-20 |
| Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma Tezepelumab, Placebo - Asthma, Allergic | Phase 2 | Unknown | McMaster University | 34 | 2023-04-01 | 2023-02-23 |
| Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults Antipyrine-benzocaine otic solution, Glycerin with Oxyquinoline Sulfate - Asthma | Phase 2 | Unknown | Global United Pharmaceutical Corporation | 50 | 2023-04-01 | 2023-02-08 |
| A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma 610 100mg, 610 300mg, placebo - Asthma | Phase 2 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 120 | 2022-09-01 | 2022-09-06 |
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma GR1802 injection, Placebo - Asthma | Phase 2 | Unknown | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 150 | 2022-07-19 | 2024-10-15 |
| A Study of MG-K10 in Subjects With Asthma MG-K10, Placebo - Asthma | Phase 1 / Phase 2 | Unknown | Shanghai Mabgeek Biotech.Co.Ltd | 180 | 2022-07-05 | 2023-08-21 |
| Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations Standard care, Eosinophil-directed care - Asthma Attack, Asthma | Phase 2 | Unknown | Changi General Hospital | 110 | 2022-06-02 | 2024-08-21 |
| Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome Ruxolitinib - Bronchiolitis Obliterans Syndrome, Hematologic Malignancy | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 50 | 2022-06-01 | 2022-10-19 |
| Efficacy and Safety of Low-dose Ibrutinib and Itraconazole in Chronic Graft Versus Host Disease Low-dose ibrutinib - Chronic Graft-versus-host-disease | Phase 2 | Unknown | Hospital Universitario Dr. Jose E. Gonzalez | 13 | 2022-04-01 | 2022-04-27 |
| A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia Orelabrutinib( lower dose), Orelabrutinib( higher dose) - Primary Immune Thrombocytopenia | Phase 2 | Unknown | Beijing InnoCare Pharma Tech Co., Ltd. | 30 | 2022-02-21 | 2023-01-12 |
| Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer Osimertinib Oral Tablet - Carcinoma, Non-Small-Cell Lung | Phase 2 | Unknown | Qingdao Central Hospital | 20 | 2021-07-01 | 2023-03-29 |
| Benralizumab Initiated During Severe Asthma Attack Benralizumab 30 MG/ML [Fasenra], Placebos - Asthma Attack, Asthma | Phase 2 | Unknown | Singapore General Hospital | 128 | 2021-06-02 | 2021-07-23 |
| Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) Benralizumab, Prednisolone - Asthma, COPD | Phase 2 | Unknown | University of Oxford | 158 | 2021-03-29 | 2024-01-23 |
| MSC for Treatment of cGVHD After Allo-HSCT Mesenchymal stem cells, Glucocorticoids, cyclosporine - Chronic Graft-versus-host Disease | Phase 2 | Unknown | Nanfang Hospital, Southern Medical University | 152 | 2021-01-10 | 2020-12-31 |
| A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang Weiyang Yuping Fang - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 84 | 2020-10-01 | 2023-05-25 |
| Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics Magnesium Sulfate, Placebo - Asthma in Children | Phase 2 / Phase 3 | Unknown | Oman Medical Speciality Board | 90 | 2020-08-01 | 2020-07-13 |
| Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis Roflumilast, Placebo oral tablet - Bronchiectasis Adult | Phase 2 | Unknown | University of Sao Paulo General Hospital | 30 | 2019-12-06 | 2020-01-13 |
| Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline Minocycline Topical, Placebos - Allergic Rhinitis, Asthma | Phase 2 | Unknown | State University of New York - Downstate Medical Center | 25 | 2019-09-26 | 2021-10-14 |
| Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis S-1226 - Cystic Fibrosis, Bronchiectasis | Phase 2 | Unknown | SolAeroMed Inc. | 12 | 2019-08-08 | 2021-06-16 |
Showing 20 of 66. Sign in to see all of them.
Asthma (31) · Bronchiolitis Obliterans Syndrome (21) · Bronchiectasis (5) · Bronchial Neoplasms (3) · Leukemia (3) · Bronchiolitis (2) · Bronchiolitis Obliterans (2) · Bronchitis (2) · Carcinoma, Bronchogenic (2) · Carcinoma, Non-Small-Cell Lung (2) · Conjunctivitis, Allergic (2) · Graft vs Host Disease (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lung Diseases (2) · Lung Neoplasms (2)
Respiratory Tract Diseases (64) · Lung Diseases (60) · Lung Diseases, Obstructive (58) · Immune System Diseases (53) · Hypersensitivity, Immediate (32) · Hypersensitivity (31) · Respiratory Hypersensitivity (31) · Bronchitis (25) · Bronchiolitis (23) · Bronchiolitis Obliterans (21) · Organizing Pneumonia (21) · Graft vs Host Disease (19) · Pathological Conditions, Signs and Symptoms (15) · Pathologic Processes (11)
montelukast (4) · Glucocorticoids (3) · Budesonide (2) · Cyclosporine (2) · Formoterol Fumarate (2) · Interferon-gamma (2) · Saline Solution (2) · Saline Solution, Hypertonic (2) · benralizumab (2) · Albuterol (1) · Alemtuzumab (1) · Antirheumatic Agents (1) · Beclomethasone (1) · Bevacizumab (1) · Bortezomib (1)
Shanghai University of Traditional Chinese Medicine (5) · Nanfang Hospital, Southern Medical University (4) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Technische Universität Dresden (2) · Baylor Research Institute (1) · Beijing InnoCare Pharma Tech Co., Ltd. (1) · Belfast Health and Social Care Trust (1) · Canadian Institute of Natural and Integrative Medicine (1) · Changi General Hospital (1) · Charite University, Berlin, Germany (1) · Chinese Academy of Medical Sciences (1) · Chronic Lymphocytic Leukemia Research Consortium (1) · Daejeon University (1) · Drugs for Neglected Diseases (1) · Federal State Budgetary Institution, Pulmonology Scientific Research Institute (1)
China (19) · United States (9) · United Kingdom (7) · Germany (6) · Canada (3) · South Korea (3) · Mexico (2) · Singapore (2) · Austria (1) · Belgium (1) · Bolivia (1) · Brazil (1) · Chile (1) · Finland (1) · India (1)
Zhenhui Lu, Doctor (2) · Agnieszka Brzozowska, MD, PhD (1) · Alan Miller, MD, PhD (1) · Alberto Papi, MD (1) · Andreas M Zeiher, MD (1) · Andrew Wilson, MD, MRCP (UK) (1) · Anthony Yii, MB BChir (1) · Antonio Jimenez, Dr. (1) · Arnon Krongrad, MD (1) · Badri Rickhi, MB,BS,FRCPC (1) · Birgit Assmus, MD (1) · Blanca Xicoy, Dr. (1) · Christian Vogelberg, MD PhD (1) · Christopher Corrigan, MD, PhD (1) · Chunhua Zhao, MD,PHD (1)
PMID 11756187, PMID 16164444, PMID 18595980, PMID 18827155, PMID 19047234, PMID 19439742, PMID 20100768, PMID 20399493, PMID 20634158, PMID 20965785, PMID 21471175, PMID 21771118, PMID 21978929, PMID 22093109, PMID 22270499, PMID 22579125, PMID 23047831, PMID 23114233, PMID 23440689, PMID 23481463, PMID 23704092, PMID 24166905, PMID 24323036, PMID 25138330, PMID 25344148, PMID 25349312, PMID 25445859, PMID 26178642, PMID 26686407, PMID 27609406, PMID 27609408, PMID 27824606, PMID 28218239, PMID 29764875, PMID 29973284, PMID 30326954, PMID 30472801, PMID 31260802, PMID 31310686, PMID 31515828, PMID 31664782, PMID 31668569, PMID 3295741, PMID 33836161, PMID 34668977, PMID 34857814, PMID 37438187, PMID 38485149, PMID 38546375, PMID 38687061
2018 (2), 2009 (1), 2017 (1)